Menu Menu


PRTG Financials       Clear


PRTG        0001095435    
Filing Date Form Type Description Document
2016-05-26 6-K PORTAGE ANNOUNCES ORPHAN DRUG DESIGNATION REQUEST GRANTED FTO BIOHAVEN FOR BHV 4 View Document
2016-04-27 6-K BIOHAVEN APPOINTS CHIEF COMMERCIAL OFFICER View Document
2016-04-07 6-K PORTAGE PROVIDES CORPORATE UPDATES View Document
2016-03-23 6-K PORTAGE INVESTS FURTHER IN BIOHAVEN View Document
2016-03-21 6-K ORPHAN DRUG DESIGNATION RECEIVED BY BIOHAVEN View Document
2016-03-14 6-K ANNOUNCEMENT OF PROPOSED PRIVATE PLACEMENT View Document
2016-02-26 6-K THIRD QUARTER 16 FINANCIALS AND MDA View Document
2016-02-25 6-K EXPEDITED DEVELOPMENT PATH FOR BHV 0223 FOR BIOHAVEN View Document
2016-02-25 6-K POSITIVE RESULTS FROM PHASE 1 STUDY WITH BHV-0223 View Document
2016-02-08 6-K NOTICE OF RECORD AND MAILING DATE View Document
2016-01-25 6-K PORTAGE PROVIDES PPL UPDATES View Document
2015-12-01 6-K INTERIM FINANCIALS FOR THE SIX MONTHS ENDED SEPT 30, 2015 View Document
2015-11-23 6-K BIOHAVEN PHASE 1 TRIALS View Document
2015-10-06 6-K BIOHAVEN COMPLETES MULTIPLE DOSING IN PHASE ONE TRIAL View Document
2015-10-02 6-K STRATEGIC ALLIANCE WITH FOX CHASE CHEMICAL View Document
2015-09-21 6-K BIOHAVEN COMPLETES SINGLE DOSE PHASE View Document
2015-09-21 6-K PORTAGE ISSUES LETTER TO SHAREHOLDERS View Document
2015-08-31 6-K PPL ADVANCES ITS PPL-003 TO AN IND View Document
2015-08-27 6-K BIOHAVEN DOSES FIRST HUMAN SUBJECT IN PHASE 1 TRIAL View Document
2015-08-26 6-K QUARTERLY FINANCIALS AND MDA 6.30.2015 View Document
2015-08-25 6-K PORTAGE BIOHAVEN INDA GETS CLEARANCE FORM FDA View Document
2015-08-21 6-K BIOHAVEN ACQUIRES NEW IPS View Document
2015-08-11 6-K BIOHAVEN RAISES $4.1 View Document
2015-08-11 6-K PORATGE INVESTS IN SENTIEN View Document
2015-07-30 20-F ANNUAL REPORT View Document
2015-07-23 6-K PORTAGE'S BIOHAVEN FILES AN INDA View Document
2015-06-25 6-K COMPLETION OF PRIVATE PLACEMENT View Document
2015-06-17 6-K PORTAGE CLOSES FIRST TRANCHE OF PRIVATE PLACEMENT View Document
2015-05-19 6-K PROPOSED PRIVATE PLACEMENT View Document
2015-04-22 6-K BIOHAVEN UPDATE View Document
2015-04-21 6-K PPL UPDATE View Document
2015-04-16 6-K PORTAGE ATTENDING INVESTOR MASTER SHOW IN UK View Document
2015-04-01 6-K BIOHAVEN UPDATE RE INVENTIV View Document
2015-03-25 6-K BIOHAVEN UPDATE View Document
2015-03-17 S-8 2013 OPTION PLAN REGISTRATION View Document
2015-02-18 6-K FINANCIALSTATEMENTSFEB15 View Document
2015-02-12 SC 13D/A SC 13D/A View Document
2014-12-18 6-K BIOHAVEN UPDATE View Document
2014-12-16 6-K PPL UPDATE View Document
2014-11-28 6-K PORTAGEFINANCIALS2Q15 View Document
2014-10-16 6-K CLOSURE OF PRIVATE PLACEMENT View Document
2014-10-08 6-K APPOINTMENT OF ADDITIONAL CONSULTANTS View Document
2014-09-29 6-K CONVERSION OF DEBTS INTO EQUITY View Document
2014-09-24 6-K PORTAGE APPOINTS NEW CONSULTANTS View Document
2014-08-13 6-K QUARTERLY FINANCIALS View Document
2014-08-06 6-K BIOHAVEN PATENT APPROVAL View Document
2014-07-31 20-F ANNUAL REPORT View Document
2014-07-14 6-K SUCCESSFUL VALIDATION OF PEPTIDE PLATFORM TECHNOLOGY View Document
2014-05-21 424B3 View Document
2014-05-21 424B3 View Document
2014-05-16 6-K PORTAGE SIGNS A COLLABORATIVE RESEARCH AND DEVELOPMENT AGREEMENT WITH US NATIONA View Document
2014-05-09 424B3 View Document
2014-05-09 424B3 View Document
2014-05-08 6-K View Document
2014-05-06 424B3 View Document
2014-05-06 424B3 View Document
2014-05-05 6-K PORTAGE?S BIOHAVEN ISSUED NOTICE OF ALLOWANCE: GLUTAMATE AGENTS IN THE TREATMENT View Document
2014-04-14 424B3 View Document
2014-04-14 424B3 View Document
2014-04-11 6-K PORTAGE PROVIDES UPDATES View Document
2014-02-26 424B3 View Document
2014-02-26 424B3 View Document
2014-02-26 424B3 View Document
2014-02-26 424B3 View Document
2014-02-25 6-K PORTAGE REPORTS THIRD QUARTER FINANCIAL RESULTS View Document
2014-02-25 6-K PORTAGE BIOTECH INC. THREE AND NINE MONTHS ENDED DECEMBER 31, 2013 View Document
2014-02-12 424B3 View Document
2014-02-12 424B3 View Document
2014-02-11 6-K FORM 6-K COVER SHEET View Document
2014-01-31 SC 13D/A FORM SC 13D/A View Document
2014-01-29 SC 13G/A FORM SC 13G/A View Document
2014-01-07 424B3 View Document
2014-01-07 424B3 View Document
2014-01-07 6-K PORTAGE ACQUIRES MAJORITY INTEREST IN BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LI View Document
2013-12-23 424B3 View Document
2013-12-23 424B3 View Document
2013-12-19 S-8 FORM S-8 View Document
2013-12-18 424B3 View Document
2013-12-18 424B3 View Document
2013-12-17 6-K PORTAGE LAUNCHES NEW WEBSITE AND PROVIDES UPDATE ON ITS R&D ACTIVITIES View Document
2013-12-17 424B3 View Document
2013-12-17 424B3 View Document
2013-11-26 6-K PORTAGE BIOTECH INC. THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2013 View Document
2013-11-13 424B3 View Document
2013-11-13 424B3 View Document
2013-11-12 6-K PORTAGE APPOINTS SCIENTIFIC ADVISORY BOARD View Document
2013-10-29 424B3 View Document
2013-10-29 424B3 View Document
2013-10-28 6-K/A AMENDED PRESS RELEASE DATED OCTOBER 25, 2013 View Document
2013-10-28 424B3 View Document
2013-10-28 424B3 View Document
2013-10-25 6-K PORTAGE ANNOUNCES LISTING ON CANADIAN NATIONAL STOCK EXCHANGE View Document
2013-08-30 424B3 View Document
2013-08-30 424B3 View Document
2013-08-29 6-K PORTAGE BIOTECH INC. FINANCIAL STATEMENTS AND MD&A FOR THE QUARTER ENDED JUNE 30 View Document
2013-08-23 424B3 View Document
2013-08-23 424B3 View Document
2013-08-22 6-K PORTAGE BIOTECH INC?S NAME CHANGE AND NEW TRADING SYMBOL APPROVED BY FINRA View Document
2013-08-07 424B3 View Document
2013-08-07 424B3 View Document

Find registration statements, periodic reports, and other forms by typing ticker symbol of a company.

Ticker:

Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.



We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas